For successful drug development,
we are organizing the Scientific Advisory Board (SAB) by consulting with authorities in each field and discussing with renowned experts around the world.

For successful drug development
We are organizing the Scientific Advisory Board(SAB)
by consulting with authorities in each field
and discussing with renowned experts around the world.

Drug Development Research

Thomas M. Roberts, PhD.
  • Former Chairman, Department of Cancer Biology at the Dana-Farber Cancer Institute 
  • Former Dean of Graduate Education at Harvard Medical School

Contributing to the research of Ciba-Geigy, Key role in the development of Gleevec, which is one of the first molecularly-targeted cancer therapies. 


 Extracellular Vesicle (EV) Research

Kenneth Whitaker Witwer, Ph.D.
  • Associate Professor, Johns Hopkins University School of Medicine
  • President-Elect, International Society for Extracellular Vesicles

World-class researcher in EVs 


Drug Development Research

Thomas M. Roberts, PhD.
  • Former Chairman, Department of Cancer Biology at the Dana-Farber Cancer Institute 
  • Former Dean of Graduate Education at Harvard Medical School

Contributing to the research of Ciba-Geigy, Key role in the development of Gleevec, which is one of the first molecularly-targeted cancer therapies. 


 Extracellular Vesicle (EV) Research

Kenneth Whitaker Witwer, Ph.D.
  • Associate Professor, Johns Hopkins University School of Medicine
  • President-Elect, International Society for Extracellular Vesicles

World-class researcher in EVs